Log in to save to my catalogue

Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission

Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e8520ed8a9ea4ad4a6eebc0252da84a4

Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission

About this item

Full title

Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission

Publisher

London: Nature Publishing Group UK

Journal title

Blood cancer journal (New York), 2024-07, Vol.14 (1), p.108-7, Article 108

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

In patients with relapsed DLBCL in complete remission (CR), autologous hematopoietic cell transplantation (auto-HCT) and CAR-T therapy are both effective, but it is unknown which modality provides superior outcomes. We compared the efficacy of auto-HCT vs. CAR-T in patients with DLBCL in a CR. A retrospective observational study comparing auto-HCT...

Alternative Titles

Full title

Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_e8520ed8a9ea4ad4a6eebc0252da84a4

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e8520ed8a9ea4ad4a6eebc0252da84a4

Other Identifiers

ISSN

2044-5385

E-ISSN

2044-5385

DOI

10.1038/s41408-024-01084-w

How to access this item